share_log

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $50

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $50

HC Wainwright & Co.维持对 Tarsus Pharmicals 的买入,将目标股价提高至 50
Benzinga ·  2023/07/26 06:10

HC Wainwright & Co. analyst Oren Livnat maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $44 to $50.

HC Wainwright & Co. 分析师奥伦·利夫纳特维持Tarsus Pharmicals(纳斯达克股票代码:TARS)的买入,并将目标股价从44美元上调至50美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发